MediGene granted Triton exclusive, Canadian rights to develop and commercialize Veregen sinecatechins ointment to treat genital warts

Medigene AG

Germany / Small-Cap Biopharma (<$1 billion)

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Triton Pharma Inc.

Canada / Private Biopharma

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced